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Intensive investigative efforts probing the many characteris-
tics and potential functions of the renin-angiotensin system
(RAS) have resulted in an exponentially expanding literature. In
this editorial, we focus on the renal hemodynamic influences
exerted by the RAS as a local regulatory mechanism. Indeed,
local control was one initial function ascribed to the RAS by
early investigators in this area. Because of its unique structure,
the juxtaglomerular apparatus, now known to be the major site
of renin formation, intrigued morphologists. It was postulated
that the cells of the juxtaglomerular apparatus could control
blood flow through the glomerulus by swelling and shrinking the
afferent arteriolar lumen [1]. The unique juxtaposition of the
macula densa cells of the early distal tubule to the glomerular
arterioles also suggested mechanisms linking the function of the
tubules with that of the arterioles [2—4]. Goormaghtigh [5]
proposed an endocrine function for the juxtaglomerular appara-
tus and demonstrated uncanny insight in postulating the release
of an agent by this structure that could activate or form a
vasoactive substance which, in turn, influenced local vascular
tone. Although some investigators continued to support the
notion that local control was a major function of the RAS [6—8],
the major areas of investigation in this field were oriented
toward non-renal functions of the system such as in the control
of aldosterone release, the regulation of systemic cardiovascu-
lar function, and the pathophysiology of hypertension [9].
Recent investigations, however, have renewed enthusiasm re-
garding the possibility that locally formed angiotensin II (All)
may participate as an important modulator of renal vascular
tone.
Intrarenal localization of components of the renin-angiotensin
system
Renin, the proteolytic enzyme that cleaves angiotensin I (At)
from renin substrate (angiotensinogen) is formed by the granu-
lar cells of the juxtaglomerular apparatus [6—111. While it has
often been accepted that renin is secreted directly into the
vascular compartment [8, 10, 11], it is now appreciated that this
may not be as significant as the secretion of renin into the
interstitium [6, 12—15]. Renin is thus secreted predominantly
into the surrounding interstitial spaces where it acts on avail-
able substrate to form Al in the tissues. Subsequent entry of
renin and the angiotensin peptides into the circulation presum-
ably occurs at the level of the peritubular capillaries. Micro-
puncture studies have demonstrated that the renin concentra-
tion of blood collected from efferent arterioles is similar to the
arterial blood levels even when renal venous blood has much
higher renin concentrations [13, 14]. Furthermore, measure-
ments of renin and All concentrations in renal lymph or kidney
tissue indicate that the interstitial concentrations are much
greater than can be predicted from the renal venous plasma
concentrations [15—171. Since renin is a large molecule, it can be
readily appreciated that the peritubular capillary system would
restrict its passage from the interstitium into the vasculature. It
is less clear, however, how the angiotensin peptides which
should readily permeate the capillary system fail to equilibrate
between interstitial and vascular compartments. Nevertheless,
Bailie, Rector, and Seldin [15] found that lymph All concentra-
tions were over 100 times greater than plasma levels, and
Mendelsohn [17] reported that tissue All levels were 10 to 20
times greater than that of plasma. The means by which these
large gradients can be maintained is presently unexplained;
although, it is possible that much of the tissue angiotensin is in
some bound form or even intracellular [12, 17—191.
The presence of angiotensin converting enzyme (ACE) within
the kidney [12, 20—22] provides the basis for the hypothesis that
A!, formed within the kidney or delivered in the arterial blood,
can be converted to All locally. To the extent that ACE activity
is present extravascularly, intrarenally formed All could accu-
mulate in the interstitium and influence surrounding vascular or
tubular structures. Where All is formed intravascularly, it
could influence the segments at or downstream from the
converting sites [10, 21]. The possible role of intracellular All
[12, 18, 19, 23] has not yet been explored in detail.
Immunohistochemical techniques involving the administra-
tion of specific antibodies to renin, renin substrate, Al, All, and
ACE have led to detailed information on the intrarenal localiza-
tion of the components of the RAS [12, 18, 19, 23—25]. As
expected, the highest renin immunoreactivity has been demon-
strated in the epitheloid granular cells of the juxtaglomerular
apparatus [12, 18]. Several studies have now demonstrated that
All immunoreactivity co-exists within these same cells [12, 18,
19, 24]. In rats treated with ACE inhibitor, Al immunoreactivity
was also found in the juxtaglomerular cells [23]. Angiotensin
converting enzyme immunoreactivity has been observed pri-
marily on the luminal surface of the endothelial cells lining the
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arteries and arterioles including the afferent and efferent arter-
ioles of the kidney [12, 23]. There was less reactivity in the
endothelial cells of glomerular capillaries and peritubular capil-
laries [12]. The presence of A!! within the renin-containing
epithelial cells suggests that ACE is also present inside the
granular cells [23] or that All is taken up by these cells [241.
Rightsel et al [25] reported that a monolayer cell culture of
juxtaglomerular cells contains immunoreactivity of renin, ACE,
and angiotensins I. II, and III. Thus, as depicted in Figure 1, all
of the components necessary for the intrarenal and perhaps
intracellular formation of All are present and available within
the kidney in the immediate vicinity of the juxtaglomerular
apparatus.
There is also abundant ACE in the capillaries of the lung and
other tissues; the major fraction of the Al entering the lung
circulation is converted to All [22, 26—28]. The amount of
extrarenally formed All depends on available Al which de-
pends primarily on the circulating levels of renin, but also on
the available substrate. Therefore, it should also be recognized
that many of the effects of the renin-angiotensin system on renal
function could be mediated by preformed All delivered in the
arterial blood. In fact, most of the information available regard-
ing the renal actions of All has been obtained by evaluating the
renal hemodynamic responses to systemic or intra-arterial All
infusions [29]. In many circumstances, the actual discrimination
between those effects mediated by locally formed All and those
effects mediated by systemically delivered All is a formidable
challenge not always appreciated by investigators.
The possible role of systemically delivered Al to organs
having endothelial cell-bound ACE has generally been ignored;
yet, several investigators have reported unexpectedly high Al
concentrations in arterial blood [30—33], renal lymph [12] and
homogenates of rat kidney [19]. Boyd and Peart [31] reported
concentrations of A! in normal human plasma that were higher
than the All concentrations. In anesthetized dogs [32, 33], Al
concentrations were about ten times higher than the All con-
centrations. Clearly, these Al concentrations are not inconse-
quential and could exert substantial effects on renal function
subsequent to the intrarenal conversion to All. Further studies
are necessary to eliminate possible methodological reasons for
Fig. I. Schematic representation of
localization of components of renin-
angiotensin system within the renal
vasculature (membrane bound or
intracellular). The representation is based on
recent immunohistochemical and
autoradiographic studies [12, 18, 19, 23—25,
41, 44].
these unexpectedly high Al concentrations, as well as to
determine if changes in circulating Al concentrations also
contribute to adjustments in renal vascular tone.
Vascular target sites for angiotensin
Many studies have established the presence of angiotensin
receptors on vascular smooth muscle cells from several tissues
[34—36], and it is generally accepted that smooth muscle cells of
the renal vasculature are also highly responsive to angiotensin
with the interesting exception of the large arterioles of the
kidney [36]. Recent studies demonstrating the presence of
angiotensin receptors on the intraglomerular structures have
stimulated speculation regarding the role of angiotensin-depen-
dent mesangial contractility on various aspects of glomerular
function.
Studies regarding contractile capabilities of glomerular cells
were initiated by Bernik [37] using cultured cells from human
glomeruli. She observed that some cells exhibited contractile
activity and suggested that they were of mesangial origin. It was
also noted that glomeruli with intact capillary loops exhibited
rhythmic and near synchronous contractions apparently caused
by cells lining the capillary loop and located in a pen- or
intercapillary position. The notion that the glomerular cells
have contractile capabilities prompted investigators to evaluate
the effects of various agents. Hornych, Beaufils, and Richet [38]
observed apparent vasoconstriction of the glomerular capillar-
ies and distinct changes in the epithelial cells from superficial
glomeruli caused by All. The effects were blocked by the
administration of anti-angiotensin plasma. These responses to
angiotensin were diminished in glomeruli isolated from rats
maintained on a high sodium diet and enhanced in those taken
from sodium-depleted rats [39].
It has also been demonstrated that there are specific angio-
tensin binding sites in the glomerular capillaries [40—43]. Sraer
et al [40] showed that iodinated All bound to isolated glomeruli
and that All decreased mean glomerular diameter. Specific
binding represented more than 95% of the total binding. Using
tritiated All, Osborne et at [41] concluded that the predominant
glomerular binding sites were localized to glomerular mesangial
cells. Less mesangial radioactivity was found in sodium-de-
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prived rats than in those receiving high salt intake. Presumably,
the high endogenous All levels in low sodium rats resulted in a
greater receptor occupancy limiting receptor availability to
labelled All. There may also be a reduction in the number of the
All receptors in states of sodium deficiency [42]. Sraer et al [43]
found high affinity binding of '251-AII to glomerular basement
membranes that accounted for approximately 20% of the total
glomerular binding sites. They suggested that a protein local-
ized in the glycoprotein moiety of the basement membrane
served as a binding site and that interactions of All with the
glomerular basement membrane could be involved in the angio-
tensin-induced changes in glomerular permeability. Brown,
Douglas, and Krontini-Litowitz [44] demonstrated that glomer-
uli have a single class of specific All receptors that share more
properties in common with receptors of the adrenal glomerulosa
than of uterine smooth muscle, suggesting that the receptors
localized to the glomeruli are not identical to those present in
vascular smooth muscle cells,
In studies of homogenous cell cultures of glomerular origin,
Ausiello et al [45] demonstrated that cells of apparent mesangial
origin exhibited a contraction-like phenomenon when All or
arginine vasopressin was added. Cloned rat glomerular epitheli-
al cells failed to exhibit a similar contractile response. Kreis-
berg [46] indicated that insulin may be required for the manifes-
tation of the contractile response to All. These studies further
implicate the mesangial cells as potential intraglomerular ele-
ments regulating flow along the glomerular capillaries and total
surface area available for fluid flux across the capillaries.
However, the influence of angiotensin on in vivo function of the
mesangial cells has not been established definitively.
Direct angiotensin effects on renal hemodynamics
Although evaluation of the effects of exogenous All may not
provide direct insight regarding the function of intrarenally
formed All, such studies have demonstrated the responsive-
ness of the renal vasculature [29]. Also, the administration of Al
or renin substrate into the renal artery has provided one means
of evaluating the effects of enhanced intrarenal ALL formation.
Angiotensin II elicits dose-dependent decreases in renal
blood flow (RBF) and smaller more variable effects on glomeru-
lar filtration rate (GFR) such that filtration fraction increases
[29, 47, 48]. Also, moderate infusions of angiotensin do not
prevent normal autoregulatory adjustments in vascular resist-
ance following reductions in arterial pressure [49, 50]. Because
of the greater reductions in RBF than GFR, it has been
suggested that All exerts a preferential effect on efferent
arterioles [51, 52]; however, this is not the most appropriate
explanation since increases in filtration fraction can occur even
with balanced increases in pre- and postglomerular resistances
[53, 54]. In micropuncture experiments, it has been observed
that All infusions reduce single nephron glomerular filtration
rate (SNGFR) and glomerular plasma flow, the latter being
proportionately greater [55]. Afferent and efferent arteriolar
resistances increased and the glomerular filtration coefficient
(Kf) was decreased [56—58]. While most of the observed in-
creases in afferent resistance appeared to be mediated by
autoregulatory responses to the elevated systemic arterial pres-
sure, some studies [56—58] suggest that the changes in afferent
arteriolar resistance are greater than could be attributed specifi-
cally to the autoregulatory mechanism. Schor, Lchikawa, and
Brenner [58] recognized that afferent arterioles may respond to
All especially when high local levels are achieved. Using the
hamster cheek pouch preparation with grafted renal embryonic
tissue, Click, Joyner, and Gilmore [59] demonstrated that
afferent and efferent arterioles responded to angiotensin and
these responses were augmented in hypertension. The effects
appeared to be slightly greater on the efferent arteriole.
When angiotensin was infused during concomitant inhibition
of prostaglandin synthesis, it was found that the effects of AL!,
in particular on the preglomerular resistance, were much more
pronounced [57]. These results are consistent with the findings
that angiotensin can stimulate intrarenal production of vasodila-
tor prostaglandins [58, 60—63], which, in turn, help protect the
renal circulation from the vasoconstrictor effects of All. Thus,
the relative status of the prostaglandin system in the renal
vascular cells may help determine the actual resistance alter-
ations observed in response to All and other vasoconstrictors
[63]. Furthermore, it is possible that the counteracting effects of
prostaglandins on afferent arteriolar resistance are responsible
for the apparent lack of responsiveness to All observed under
some conditions.
In microperfusion studies, it was shown that ALL infused
directly into peritubular capillaries increased peritubular capil-
lary and proximal tubule pressures [64]. There was also a
reduction in the diameters of the peritubular capillaries [65].
These results suggest that All also influences peritubular capil-
lary dynamics through effects on capillary or venous resistance
elements. These studies using exogenous ALl infusions demon-
strate that, at least under certain specific conditions, essentially
all components of the renal microvasculature can respond to
All.
There is no consensus regarding the effects of angiotensin on
the regional RBF distribution due to the different responses
observed with the different flow measurement methods [66—71].
Studies have demonstrated a primary outer cortical vasocon-
strictor effect as well as uniform decreases in cortical blood
flow. Similar blood flow reductions in the cortex and medulla
have also been observed during All injections. Despite these
methodological uncertainties, it can be concluded that all
regions of the renal vasculature respond to exogenous All, but
subtle quantitative differences in regional sensitivity may exist.
As one means of evaluating the effects of enhanced intraren-
ally formed All, investigators have infused either Al or renin
substrate into the renal artery [48, 71—76]. In isolated perfused
kidneys, it was shown that substantial intrarenal formation of
All occurred in the initial pass during infusion of Al or renin
substrate [7 1—73]. Similar demonstrations of local conversion in
in vivo experiments have been more difficult because recircula-
tion of blood from the kidney back to the aorta occurs in only a
few seconds causing an additional vasoconstriction by the All
converted in the lung. An opportunity to demonstrate convinc-
ingly the effects of locally converted All presented itself to us in
the form of a dog with two separate renal arteries going to the
same kidney. RBF was measured in both arteries and At was
infused into one. As shown in Figure 2, there were definitive
dose-dependent decreases in the blood flow of the infused renal
artery with only small changes in blood flow occurring in the
non-infused renal artery. Thus, it is clear that the renal vascula-
ture is capable of forming All in response to the infusion of
precursors and that the locally formed All can elicit direct
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Fig. 2. Demonstration of the dose-dependent RBF reductions due to
enhanced intrarenally formed angiotensin II during intrarenal arterial
angiotensin I infusion localized to the infused renal arter,' in a kidney
with two renal arteries.
effects on renal hemodynamics. Similar effects have been
observed when the nanopeptide was infused into the renal
artery leading to the formation of the heptapeptide, angiotensin
III [76]. The actual magnitude of angiotensin conversion within
the kidney is uncertain; estimates have varied from I to 20%
[33, 72, 75—79], Recent studies in our laboratory utilizing
infusions of tracer doses of radiolabelled A! yielded conversion
rates above 20% [33].
The hemodynamic responses occurring during enhanced lo-
cal generation of Al! subsequent to infusion of renin substrate
or AL have been studied under several circumstances [48, 71—
76]. While increases in total renal vascular resistance have been
uniformly observed, there are substantial uncertainties in terms
of the intrarenal hemodynamic adjustments. With regard to
regional changes in blood flow, it has been suggested that
locally generated All might reduce inner cortical blood flow to a
slightly greater extent than exogenous All [71, 75]. A more
prominent controversy is related to the possible segmental
localization of the renal vascular resistance adjustments caused
by enhanced intrarenal All formation. The isolated perfused
kidney studies using cell-free perfusates were interpreted as
suggesting that the angiotensin-mediated increase in renal vas-
cular resistance was localized predominantly to postglomerular
resistances [73]. However, this interpretation failed to consider
possible direct effects of angiotensin on proximal tubule dynam-
ics, as well as on the glomerular filtration coefficient [56—581.
In an attempt to evaluate in greater detail the effects of
enhanced local All formation mediated by Al infusion, we
conducted an extensive series of experiments comparing the
effects of intra-arterial infusion of equiconstrictor doses of Al
and All [48]. The whole kidney responses are summarized in
Figure 3. As shown, both A! and All elicited decreases in GFR.
It appeared paradoxical, however, that the decreases in GFR
Fig. 3. Effects of intrarenal arterial infusions of angiotensin I (•—•)
and angiotensin II (0 0) in equiconstrictor doses on RBF, GFR,
and filtration fraction (FF) [48]. To reduce endogenous levels of
angiotensin, dogs were maintained on a high sodium diet prior to the
experiment. In these experiments (N II), the systemic arterial blood
pressures were maintained on spontaneous levels. The equivalent
decreases in RBF were achieved by infusing the Al at 1.15 0.15
sg/min and the All at 0.28 0.05 gJmin into the renal artery. Data are
shown as means SE. The asterisk (*) indicates that values obtained
during angiotensin infusions are significantly different from control
values (P < 0.05).
were more consistent during the Al infusions [48]. Neverthe-
less, it was clear from these studies that intra-arterial Al
infusions led to the intrarenal formation of All which occurred
early enough to decrease GFR significantly. The reductions in
GFR observed during the infusions of both peptides coupled
with micropuncture data showing significant decreases in pen-
tubular capillary pressure and proximal tubule pressure without
significant alterations in proximal tubule stop flow pressure
suggest that both afferent and efferent arteriolar resistances are
increased in vivo by locally formed All to about the same
extent as by systemically delivered All [48].
In further micropuncture dog studies designed to evaluate the
mechanism responsible for the Al-mediated reductions in GFR,
glomerular pressure was estimated on the basis of proximal
tubule stop flow pressure [80]. With an Al infusion resulting in a
37% decrease in RBF, there were significant reductions in
single nephron GFR (40%), proximal tubule pressure (26%),
and peritubular capillary pressure (49%). Glomerular plasma
flow was calculated to decrease by 55%; however, estimated
glomerular capillary and effective glomerular pressures were
not altered significantly. These data indicate that Al exerts
FM
Navar and Rosivall860
0
'O00
C
A I lnf
100
80
60
40
20
0
Noninfused
S •
x x-X S
2' Infused
+ 4+
0.950
Control
1.15 1.55
IJ.q/min
Angiotensin I infusion Recovery
6
50'
: **
2
1.00 —
. 0.90 —0'
*
E
*0.80
—
0.70 —
0.50
.I * *
0.40
0.30
Control Angiotensin
Intrarenal role of renin-angiotensin system 861
approximately equivalent effects on both afferent (preglomeru-
tar) and efferent vascular resistances. A substantial decrease in
the glomerular filtration coefficient (45%) was also observed.
Therefore, it seems clear that an enhanced local All formation
caused by arterial Al infusions creates substantial effects on
glomerular dynamics similar to those observed for All. The
possible mechanism by which the Al infused intra-arterially can
exert effects at such early points in the vasculature remains an
intriguing, unresolved issue. It is possible that the A! affinity for
ACE on the endothelium of the preglomerular arterioles and
glomerular capillaries allows locally converted All direct ac-
cess to the adjoining contractile cells.
Renal hemodynamic responses to alterations in the activity of
the renin-angiotensin system
Many investigations have examined renal hemodynamic
function during suppressed and augmented activity of the RAS
elicited with chronic and acute stimuli and in several patho-
physiological models. Alterations in the dietary sodium chloride
content have been used often; increased salt intake suppresses
the RAS while sodium chloride restriction markedly increases
renin levels [17, 81—83]. Intrarenal levels of All, however, may
be partially dissociated from renal tissue renin activity and are
apparently not suppressed to the same extent during salt
loading [17]. Nevertheless, the basic hypothesis is that stimula-
tion of RAS leads to reduced renal hemodynamic function white
low angiotensin levels improve renal hemodynamics [51, 84—
88]. In support of this notion, Hall et al [84] increased the
sodium intake from as low as 5 to 495 mEq/day in normal dogs
and observed that RBF increased by about 30% while GFR
increased by about 20%. Other studies have failed to demon-
strate substantive differences in RBF or GFR associated with
varying levels of activity of the RAS or in sodium intake [58, 87,
89]. Lull et al [87] did not show impressive changes in renal
hemodynamics during marked alterations in sodium intake from
10 to 1500 mEq/day in studies using conscious human subjects.
Nevertheless, there was some tendency for GFR to be altered
at the extreme ranges of sodium intake. In our laboratory, we
have altered sodium intake of dogs from as low as 12 mEq/day
to over 150 mEq/day and evaluated renal function in the
unanesthetized state. Despite these large variations associated
with three to fivefold differences in plasma renin activity, the
values for PAH clearance and GFR were similar and failed to
show a significant association with salt intake. Studies on
anesthetized rats have been more consistent in that increased
salt intake or chronic sodium chloride infusions do increase
whole kidney hemodynamic function and superficial nephron
GFR [88, 90—92]. Only Horster and Thurau [91] reported
reciprocal decreases in the GFR of the deep nephrons in
response to increased sodium intake. Coelho [88] and Bonvalet
et al [92] reported that rats fed a high sodium diet or salt loaded
by saline infusions exhibited significant increases in GFR of
both superficial and deep nephrons without substantive alter-
ations in the superficial to deep SNGFR ratio.
To deplete kidneys of renin and lower circulating All levels
maximally, some studies have combined a high sodium chloride
diet with the administration of a mineralocorticoid such as
desoxycorticosterone (DOCA) [93—96]. In general, this regimen
has not caused greater changes in baseline renal hemodynamic
than the high salt diets alone. Collectively, the data indicate that
the angiotensin-dependent renal vascular tone is related to the
status of the RAS in a complex manner that must also involve
other systems. On the one hand, it is clear that the renal
hemodynamic changes occurring even with radical alterations
in sodium chloride intake are substantially less than would be
anticipated from the coincident changes in the renin-angiotensin
levels. However, studies using antagonists of the RAS, that will
be discussed subsequently, do support the notion that renal
hemodynamic function is substantially influenced by the RAS
[93]. Thus, it appears that the renal vasoconstrictive effects due
to an enhanced status of the RAS must be counterbalanced, at
least in part, by other locally acting vasodilator hormonal
systems [60—63]. Accordingly, it can be concluded that the
functional status of baseline renal hemodynamics do not pro-
vide an accurate reflection of the specific influence being
exerted by RAS.
The renin-depleted model has also been used to evaluate the
role of the renin-angiotensin system in mediating the renal
autoregulatory mechanism. Kaloyanides, Bastron, and DiBona
[94] reported that blood flow autoregulation was impaired in
isolated blood perfused dog kidneys of renin-depleted dogs.
However, other studies using in situ kidney preparations have
reported that RBF autoregulatory behavior is not perceptibly
diminished even when renin levels have been reduced below the
detection range [93, 95, 96]. The data related to GFR autoregu-
lation are more controversial since Potkay and Gilmore [93] and
Murray and Malvin [96] reported that GFR autoregulation was
not impaired while Hall, Guyton, and Cowley [95] concluded
that GFR autoregulatory capability was impaired in renin-
depleted animals. These and other data led Hall, Guyton, and
Cowley [95] to suggest that the RAS preferentially acts on
efferent resistance and exerts a progressively increasing influ-
ence on efferent arteriolar resistance as renal arterial pressure is
reduced. Consequently, in the absence of a functioning RAS,
efferent resistance was thought to decrease in response to
decreases in renal arterial pressure similarly to afferent resist-
ance. The validity of this provocative notion remains in doubt
since Murray and Malvin [96] failed to observe a dissociation
between RBF autoregulation and GFR autoregulation in
DOCA-treated salt-loaded dogs. The reasons for these discrep-
ancies remain unknown. In either case, however, it should be
emphasized that the basic autoregulatory mechanism responsi-
ble for mediating intrinsic changes in renal vascular resistance
in response to alterations in renal arterial pressure is essentially
autonomous from the renin-angiotensin system [49, 50].
In studies where renal function and overall renin release rates
have been evaluated concurrently during acute reductions in
renal perfusion pressure, it has been shown that the renin
secretion rate increases within minutes or even seconds [32, 83,
97—99]. These increases are generally greater at arterial pres-
sures near or below the lower limit of the autoregulatory range
[33, 99, 100]. To the extent that these increases in renin
secretion mediate increased intrarenal formation of angiotensin,
one would expect that there would be associated hemodynamic
responses that could be correlated with the changing angioten-
sin levels. Unfortunately, the delineation of these effects has
remained uncertain because of the concomitant autoregulatory
mediated vasodilator mechanisms that are also activated during
decreases in renal perfusion pressure [98—101]. Other extrinsic
manipulations that acutely increase renin release, such as
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increased renal venous pressure, increased ureteral pressure,
and increased plasma colloid osmotic pressure [101—104] are
also associated with intrinsic vasodilatory responses. Thus, the
predominant hemodynamic responses that occur during extrin-
sic manipulations known to increase renin release cannot be
attributed to postulated coincident increases in locally formed
All levels. It remains possible that autoregulatory induced
vasodilatory responses mask or overwhelm more subtle resist-
ance changes induced by elevated All levels. Alternatively,
acute increases in renin release due to extrinsic manipulations
may not immediately induce sufficient elevations in intrarenal
All concentrations [32, 33]. Some studies have suggested that
the intrarenal ACE, while capable of converting arterially
delivered A! to All, may not be able to convert locally
generated Al [33, 106], Although it is of substantial importance,
this issue has not been adequately investigated. Further studies
are necessary to determine the relationships between rapid
changes in intrarenal tissue levels of renin, Al and, in particu-
lar, A!!,
Other acute stimuli that increase the renin secretion rate and
involve renal vasoconstriction such as increased renal nerve
activity or overall stress associated with hemorrhage or cardio-
vascular distress are accompanied by a host of additional
stimuli that seriously hamper any interpretation regarding the
local influence of increased renin secretion [107].
These basic findings are also difficult to reconcile with the
concept that there is a close association between renin release
and local renal hemodynamic control mechanisms. It is possi-
ble, however, that whole kidney renin secretion rates do not
reflect the level of intrarenal angiotensin production and are
thus not indicative of the changes occurring in the intrarenal
environment [6, 15, 82]. A recent study by Carmines and
Tanner [105] indicates that chronic obstruction of individual
nephrons is associated with slowly developing effects to de-
crease glomerular blood flow. This effect was ameliorated in
renin-suppressed rats and during pharmacologic interruption of
the RAS, suggesting that augmented angiotensin levels can be
induced at the single nephron level, but may require several
hours to develop. Clearly, more comprehensive experimental
studies directly evaluating relationships between temporal he-
modynamic responses and changes in tissue A!! levels during
various physiological and experimental settings are necessary.
Effrcts ofblockade of renin-angiotensin activity on renal
hemodynamic function
Alternative approaches to evaluating the intrarenal effects of
angiotensin involve the use of pharmacological inhibitors or
antagonists that either block the conversion of Al to All or
directly interfere with the action of All. The responses ob-
served with these pharmacological blockers depend largely on
the pre-existing influence being exerted by the RAS [35, 89,
106, 108—Ill]. In animals having normal or enhanced renin
levels, angiotensin blockade increases RBF consistently [89,
110—116]. The GFR responses have been less consistent; some
studies have shown small increases [110, 113, 115—118] and
others have failed to demonstrate significant changes [89, 119].
Also, when there are large decreases in systemic arterial
pressure, GFR may decrease although RBF increases [114], In
all cases, the increased RBF has been predominant so that
filtration fraction has consistently decreased.
It should be emphasized that it is not possible from studies
using antagonists or blockers to determine the relative contribu-
tions of direct inhibition of locally formed All as compared to
the inhibition of circulating angiotensin [106, 111]. To determine
this, it would be necessary to manipulate intrarenal and circu-
lating angiotensin levels independently, which is a formidable
challenge in normal animals. However, the two-kidney, one-
clip Goldblatt hypertensive model exhibits a dissociation be-
tween renal renin content of the nonclipped kidney, which is
markedly depressed, and the elevated plasma renin activity [24,
83, 120, 1211. Studies using this model have demonstrated that
the renin-depleted contralateral kidney exhibits marked in-
creases in GFR and renal plasma flow during ACE inhibition
[1201. Interestingly, if the clip is first removed from the renin
rich clipped kidney prior to treatment with ACE inhibitors, then
both kidneys increase their RBF and GFR values similarly
although they have markedly different tissue renin levels [1221.
These studies are more consistent with the view that a major,
but not necessarily exclusive, means by which angiotensin
blockade elicits renal vasodilation is by decreasing or blocking
the effects of circulating All [106].
Because the predominant effect of angiotensin blockade is on
RBF and the associated GFR responses are less consistent and
smaller in magnitude, the data have often been interpreted as
suggesting that angiotensin exerts a much greater effect on the
efferent arterioles than the afferent arterioles [51, 52, 118, 123,
124]. It has also been suggested that intrarenally formed All
contributes to the maintenance of efferent arteriolar tone,
particularly when renin secretory activity is enhanced such as
during sodium restriction or reduced renal perfusion pressure
[51, 123, 124]. In some studies, GFR autoregulation has been
attenuated in sodium-restricted animals infused with angioten-
sin blockers, although RBF autoregulatory capability was not
impaired [51, 123, 1241. In contrast, other studies have not
obtained a dissociation between RBF and GFR autoregulation
following the administration of angiotensin blockers to sodium-
depleted dogs [50, 113, 125]. Findings from a recent study in
sodium-restricted dogs are shown in Figure 4 and demonstrate a
close association between RBF and GFR autoregulation during
control conditions, as well as during the administration of the
ACE inhibitor, SQ14225 [113]. These data fail to support the
notion of a rapidly acting effect of locally formed All on efferent
arterioles that occur in response to reductions in renal arterial
pressure. The reason for this discrepancy in the existing data
remains unknown.
The effects of angiotensin blockers on single nephron func-
tion have been evaluated in several micropuncture experi-
ments. Ploth et al [117] reported that SNGFR in anesthetized
hydropenic rats increased during the inhibition of ACE. Using
sodium-restricted Munich-Wistar rats, Steiner, Tucker, and
Blantz [126] observed approximately equivalent increases in
SNGFR and glomerular plasma flow of about 17% during
infusion of the angiotensin antagonist, saralasin. Glomerular
pressure was not altered significantly despite the approximately
20 mm Hg decrease in arterial pressure. Preglomerular resist-
ance decreased significantly, but some portion of this resistance
change was attributed to autoregulatory responses to the de-
creased arterial pressure. In these sodium-restricted rats, Kf
was significantly reduced below control values, a state not
significantly improved by saralasin. Interestingly, other experi-
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angiotensin on the preglomerular resistance vessels are coun-
teracted, either partially or completely, by other intrarenal
humoral systems 160—62].
ments demonstrated that the acute Kf lowering effects of
exogenous All were reversed by saralasin [127], suggesting that
factors other than angiotensin might be responsible for the
lower K1 observed in the sodium-restricted animals. It was
subsequently shown that long-term treatment (13 to 18 days) of
sodium-restricted rats with the ACE inhibitor, captopril, par-
tially restored K1 values toward the normal range [128]. It
remains unclear why long-term angiotensin blockade was nec-
essary to restore K1 although the vascular resistance adjust-
ments were rapid.
In micropuncture studies using sodium-restricted dogs, the
effects of SQ 14225 on glomerular hemodynamics were evaluat-
ed under conditions where renal arterial pressure was main-
tained constant [113]. As summarized in Figure 5, ACE inhibi-
tion led to significant increases in SNGFR and glomerular
plasma flow although glomerular pressure was not increased
significantly. Both preglomerular and efferent arteriolar resist-
ance decreased to approximately the same extent. K1 was not
altered significantly although a small upward trend was ob-
served. Collectively, the data from dogs and rats indicate that
the increased angiotensin levels that occur during salt restric-
tion exert approximately equivalent vasoconstrictor influences
on both preglomerular and efferent arteriolar vascular elements.
Furthermore, the micropuncture studies have generally not
been consistent with the concept that there is a preferential
angiotensin-dependent enhancement of efferent arteriolar
resistance during high angiotensin states. It is possible, howev-
er, that under some steady state conditions the influence of
Interaction between the tubuloglomerular feedback
mechanism and the renin-angiotensin system
Perhaps the most provocative and controversial putative
intrarenal function of the RAS is as a mediator of the tubulo-
glomerular feedback mechanism [6, 129]. This feedback mecha-
nism that operates between some component of the distal
tubule, presumably the macula densa cells, and the vascular
elements of the glomerulus, has been shown to exert a major
controlling influence on GFR [130—135]. It is unique among
control mechanisms governing GFR in that it operates at a
single nephron level and regulates the hemodynamically deter
mined inputs to that nephron in accord with its reabsorptivt
status [131]. Specifically, the tubuloglomerular feedback mech-
anism is responsive to flow-related changes in distal tubular
fluid composition such that increases in distal flow rate lead to
decreases in single nephron glomerular pressure and GFR [6,
130—135].
Thurau and Mason [6], Thurau et al [129], and Thurau [136]
postulated that flow-related changes in distal tubular sodium
chloride concentration lead to alterations in the renin activity or
renin release of the adjoining juxtaglomerular cells leading to an
increased formation of All and subsequent arteriolar vasocon-
striction. This variant of the macula densa feedback hypothesis
has remained controversial because it proposes that the macula
densa signal to increase the local renin activity of the juxtaglo-
merular apparatus (JGA) is an elevation in the sodium chloride
concentration of the fluid emerging from the ascending loop of
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Fig. 4. Relationships between renal arterial pressure and renal blood
flow (top panel), GFR (middle panel), and filtration fraction (lower
panel) in sodium-restricted dogs before and during administration of
converting enzyme inhibitor, SQ 14225. Data are shown as means 5E
and were derived from [113].
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Fig. 5. A summary of the effects of converting enzyme inhibition (SQ
14225) on glomerular plasma flow (GPF), single nephron-glomerular
filtration rate (SNGFR), glomerular capillary pressure (Pg), peritubular
capillary pressure (Pa), proximal tubular capillary pressure (Ps), filtra-
tion coefficient (Kf), afferent (Ra), and efferent (Re), arteriolar resis-
tances in sodium-restricted dogs maintained at a constant reduced
renal arterial pressure (RAP). Data were taken from [113]. The asterisk
(*) indicates a statistically significant change (P < 0.05) from control
values.
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Fig. 6. Representative relationships between late proximal peifusion
rate and stop-flow pressure measured in early proximal tubule during
control period, infusion of angiotensin converting enzyme inhibitor (SQ
14225) and during maintained infusion of converting enzyme inhibitor
plus systemic infusion of angiotensin 11. The schematic figure shows the
positions of pipettes used to evaluate tubuloglomerular feedback re-
sponses. Data were derived from a study by Ploth and Roy [144].
Henle. Such a constraint is necessary because arteriolar vaso-
constriction occurs in response to increases in the ioop of Henle
flow rate [131—135], and there is a direct relationship between
the ascending ioop of Henle flow rate and the sodium chloride
concentration of the emerging fluid [130—132]. Thus, to have
All mediate vasoconstriction, it was necessary to postulate that
increased macula densa sodium chloride caused increased renin
release, This proposal is in distinct contrast to that of other
investigators who have concluded that increased renin release
is associated with decreases in distal sodium or chloride con-
centration [10, 137—139]. Most manipulations that increase
renin release orjuxtaglomerular cell granulation such as overall
sodium depletion, reductions in arterial pressure, or increased
activity of the sympathetic nervous system are associated with
decreases in the loop of Henle flow rate and/or distal sodium
chloride concentration [10, 1371. These associations between
distal sodium concentration or delivery and renin release have
not been supportive of the concept that rapid adjustments in the
local activity of the RAS system directly mediate the vasocon-
striction in response to increases in distal flow rate.
Other evidence has accrued from studies showing that renin
activity in JGA units are higher following distal perfusion of
their respective macula densa segments with higher than normal
sodium chloride concentrations [81, 129, 140, 141]. Also, Mor-
gan and Gillies [13] reported that the renin concentration of
renal venous blood draining nephrons subjected to complete
proximal tubular blockade was decreased. Experiments evalu-
ating tubuloglomerular feedback responses in renin-depleted
kidneys have demonstrated an impaired or attentuated tubulo-
glomerular feedback responsiveness 1121, 1421. Subsequent
studies have also shown that blockers or inhibitors of the renin
angiotensin system reduce the sensitivity of the feedback
mechanism such that there are diminished glomerular pressure
and SNGFR responses to increases in distal flow rate [117, 143,
144]. Representative differences in the magnitude of the feed-
back-mediated increases in stop-flow pressure obtained during
angiotensin blockade are shown in Figure 6 [144]. It should be
emphasized that the feedback responses were attenuated to
approximately one half of normal but not abolished in the
presence of angiotensin blockade [117, 143, 144]; thus, the data
suggest that an intact RAS is not essential for the operation of
the feedback mechanism. In addition, other micropuncture
studies have failed to establish a direct or quantitative correla-
tion between renal renin content and the magnitude of the
tubuloglomerular feedback responses obtained in a variety of
experimental and pathophysiological models [145, 146].
As an alternative to the direct mediator concept, it is possible
that the local presence of All is necessary to achieve full
expression of the tubuloglomerular feedback mechanism. This
modulator hypothesis is explained in Figure 7. The key differ-
ence between the modulator and the mediator concepts is that
the modulator hypothesis does not require that angiotensin be
the direct effector constrictor agent changing in response to the
acute flow-related tubular signal. Rather the prevailing All
levels may simply contribute to the sensitivity of the contractile
elements that respond to the stimuli originating at the macula
densa cells. This modulator concept does not require that renin
release and prompt local formation of All occur during the
short time course involved in tubuloglomerular feedback re-
sponses. Instead, the macula densa sodium chloride levels as
well as the other mechanisms for renin release would determine
the steady state interstitial or intracellular All levels which, in
turn, would contribute to overall vascular sensitivity. Figure 6
also shows average tubuloglomerular feedback responses ob-
tained during continued inhibition of ACE but with superim-
posed systemic infusions of All. In the presence of an exoge-
nous source of All, the sensitivity of the tubuloglomerular
feedback mechanism was enhanced. These data support the
modulator concept since the local tissue All concentrations
were being determined primarily by the systemic All levels and
were presumably not changing during the feedback-mediated
changes in stop-flow pressure. Taken together, we feel that the
data are more consistent with the overall concept that angioten-
sin, along with other vasoactive agents, influences the tubulo-
glomerular feedback mechanism through an indirect modulator
capacity rather than as a direct mediator of the feedback
response.
Conclusion
It must be emphasized that there remains a substantial degree
of uncertainty associated with the entire question of how the
RAS influences intrarenal function. On the basis of many
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experimental findings, it is clear that all components necessary
to generate the active angiotensin peptides are present in the
kidney, that there are receptors for angiotensin in various
structures in the kidney and that the kidney can convert Al
delivered into the renal arterial circulation. The evidence sug-
gests that there may be significant compartmentalization of
intrarenal All formation including intravascular, interstitial,
and intracellular sites. Angiotensin II converted from systemi-
cally delivered Al can elicit definitive effects to reduce RBF and
GFR. From other studies, however, it is not always apparent
that renal vascular resistance exhibits a close association with
the activity of the RAS. Furthermore, it has not been convinc-
ingly demonstrated that under conditions of an increased renal
renin content and/or renin release that there is, in fact, an
increased local formation of All occurring within the same time
frame as the changes in renin content. Many conditions associ-
ated with high renin levels are not necessarily associated with
renal vasoconstrictive states,
Even when evidence is obtained to support an enhancement
of angiotensin-dependent renal vascular resistance, it remains
quite difficult to determine if the effects observed are due to
increased local formation of All or simply due to elevated
circulating levels of Al and All. Most of the observed responses
to angiotensin antagonists can be explained on the basis of
decreases in concentration or effectiveness of circulating angio-
tensin. Definitive experiments that allow a clear delineation of
this issue have been difficult to design. Future studies should
focus on the best means available to discriminate among the
effects elicited by preformed All, intrarenally converted All
formed from systemically delivered Al, enhanced interstitial
formation of All, or increased intracellular activation of the
RAS.
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